Golf Tournament Benefits Groundbreaking Cell Therapy Research
In its most successful year to date, the 2018 Greenebaum Comprehensive Cancer Center Golf Tournament raised more than $550,000 for the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center. Thirty-three foursomes played golf at the beautiful Caves Valley Golf Club on Oct. 15.
Starting in 2006, the Greenebaum Comprehensive Cancer Center Golf Tournament has evolved into a premier event for UMGCCC thanks to the leadership of Bobby Ginsberg, founder of Chesapeake Contracting Group, this year’s champion sponsor. Involved since the beginning, Bobby stepped up as chairman in 2014 with a desire to transform the tournament into an even larger benefit for the cancer center. Since then, the golf tournament has occurred every other year, raising a combined $1.5 million.
Bobby works in close partnership with Mark Bennett, who also has been involved with the golf tournament since 2006 and is the Senior Vice President of Land Development and Construction for Greenebaum Enterprises, Inc. Together, they recruit many of the golf tournament’s sponsors, foursomes, and partners.
Special thanks to Bobby and Mark for their continued drive to ensure the golf tournament’s success and for their dedication to UMGCCC’s mission. Thank you also to Stuart Weitzman and Marie Bowers for their involvement.
This year’s tournament benefited the pioneering translational research of Dr. Aaron Rapoport. His research demonstrates the potential for genetically engineered patient-derived immune cells to treat advanced and resistant forms of leukemia and lymphoma. This exciting and innovative form of cell therapy is now being applied to other types of cancers as well.